Annual Retained Earnings
-$399.58 M
-$81.41 M-25.59%
31 December 2023
Summary:
Leap Therapeutics annual retained earnings is currently -$399.58 million, with the most recent change of -$81.41 million (-25.59%) on 31 December 2023. During the last 3 years, it has fallen by -$176.60 million (-79.20%). LPTX annual retained earnings is now -1536.09% below its all-time high of -$24.42 million, reached on 31 December 2012.LPTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$451.94 M
-$18.18 M-4.19%
30 September 2024
Summary:
Leap Therapeutics quarterly retained earnings is currently -$451.94 million, with the most recent change of -$18.18 million (-4.19%) on 30 September 2024. Over the past year, it has dropped by -$64.82 million (-16.75%). LPTX quarterly retained earnings is now -957.24% below its all-time high of -$42.75 million, reached on 31 December 2013.LPTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.6% | -16.8% |
| 3 y3 years | -79.2% | -78.8% |
| 5 y5 years | -160.3% | -141.5% |
LPTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -79.2% | at low | -78.8% | at low |
| 5 y | 5 years | -160.3% | at low | -141.5% | at low |
| alltime | all time | -1536.1% | at low | -957.2% | at low |
Leap Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$451.94 M(+4.2%) |
| June 2024 | - | -$433.76 M(+4.9%) |
| Mar 2024 | - | -$413.40 M(+3.5%) |
| Dec 2023 | -$399.58 M(+25.6%) | -$399.58 M(+3.2%) |
| Sept 2023 | - | -$387.12 M(+3.7%) |
| June 2023 | - | -$373.42 M(+3.7%) |
| Mar 2023 | - | -$360.03 M(+13.2%) |
| Dec 2022 | -$318.17 M(+20.7%) | -$318.17 M(+4.0%) |
| Sept 2022 | - | -$306.07 M(+5.2%) |
| June 2022 | - | -$290.97 M(+6.2%) |
| Mar 2022 | - | -$273.95 M(+3.9%) |
| Dec 2021 | -$263.57 M(+18.2%) | -$263.57 M(+4.3%) |
| Sept 2021 | - | -$252.78 M(+4.6%) |
| June 2021 | - | -$241.65 M(+4.1%) |
| Mar 2021 | - | -$232.12 M(+4.1%) |
| Dec 2020 | -$222.99 M(+14.3%) | -$222.99 M(+3.1%) |
| Sept 2020 | - | -$216.28 M(+3.4%) |
| June 2020 | - | -$209.22 M(+3.2%) |
| Mar 2020 | - | -$202.70 M(+3.9%) |
| Dec 2019 | -$195.17 M | -$195.17 M(+4.3%) |
| Sept 2019 | - | -$187.17 M(+4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | -$179.24 M(+4.9%) |
| Mar 2019 | - | -$170.87 M(+11.3%) |
| Dec 2018 | -$153.53 M(+17.7%) | -$153.53 M(-1.0%) |
| Sept 2018 | - | -$155.01 M(+4.5%) |
| June 2018 | - | -$148.38 M(+5.2%) |
| Mar 2018 | - | -$141.02 M(+8.1%) |
| Dec 2017 | -$130.40 M(+29.5%) | -$130.40 M(+5.3%) |
| Sept 2017 | - | -$123.80 M(+5.8%) |
| June 2017 | - | -$116.99 M(+6.3%) |
| Mar 2017 | - | -$110.08 M(+9.4%) |
| Dec 2016 | -$100.67 M(+43.0%) | -$100.67 M(+10.1%) |
| June 2016 | - | -$91.43 M(+29.9%) |
| Dec 2015 | -$70.39 M(+3.2%) | -$70.39 M(-19.7%) |
| Sept 2015 | - | -$87.60 M(+7.1%) |
| June 2015 | - | -$81.78 M(+8.9%) |
| Mar 2015 | - | -$75.10 M(+10.1%) |
| Dec 2014 | -$68.20 M(+59.5%) | -$68.20 M(+12.5%) |
| Sept 2014 | - | -$60.61 M(+19.9%) |
| June 2014 | - | -$50.55 M(+9.6%) |
| Mar 2014 | - | -$46.14 M(+7.9%) |
| Dec 2013 | -$42.75 M(+75.0%) | -$42.75 M |
| Dec 2012 | -$24.42 M | - |
FAQ
- What is Leap Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Leap Therapeutics?
- What is Leap Therapeutics annual retained earnings year-on-year change?
- What is Leap Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Leap Therapeutics?
- What is Leap Therapeutics quarterly retained earnings year-on-year change?
What is Leap Therapeutics annual retained earnings?
The current annual retained earnings of LPTX is -$399.58 M
What is the all time high annual retained earnings for Leap Therapeutics?
Leap Therapeutics all-time high annual retained earnings is -$24.42 M
What is Leap Therapeutics annual retained earnings year-on-year change?
Over the past year, LPTX annual retained earnings has changed by -$81.41 M (-25.59%)
What is Leap Therapeutics quarterly retained earnings?
The current quarterly retained earnings of LPTX is -$451.94 M
What is the all time high quarterly retained earnings for Leap Therapeutics?
Leap Therapeutics all-time high quarterly retained earnings is -$42.75 M
What is Leap Therapeutics quarterly retained earnings year-on-year change?
Over the past year, LPTX quarterly retained earnings has changed by -$64.82 M (-16.75%)